Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study
BackgroundNon-Small Cell Lung Cancer (NSCLC) patients with low tumor mutational burden (TMB) showed low sensitive to conventional fractionated radiotherapy in our previous study. This study aimed to evaluate the efficacy and safety of hypofractionated radiotherapy (HFRT) in locally advanced NSCLC pa...
Saved in:
| Main Authors: | Jingyun Yang, Tianxiang Cui, Yang Zhang, Guangpeng Chen, Xinxin Wang, Jianguo Sun, Anmei Zhang, Guanghui Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557154/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01) -
Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01) -
Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01) -
A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study
by: Abba Mallum, et al.
Published: (2025-06-01) -
Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)